Results 121 to 130 of about 41,221 (142)

Potential for extending the chloramphenicol dosing interval for canine urinary tract infections

Journal of Veterinary Pharmacology and Therapeutics
AbstractCanine urinary excretion of chloramphenicol was evaluated to optimize a dosing protocol for treating urinary tract infections. Seven healthy male intact purpose‐bred Beagles and six healthy client‐owned dogs of various breeds each received a single oral 50 mg/kg dose of chloramphenicol.
Kate S. KuKanich, Elayna E. Anderson, Astrid D. Carcamo Tzic, Butch KuKanich   +3 more
openaire   +2 more sources

Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine

Pediatrics
BACKGROUNDNine-valent human papillomavirus (9vHPV) vaccines can be administered in 2 doses 6 to 12 months apart in adolescents. The impact of extended dose intervals is unknown. We report immunogenicity and safety data in adolescents of a second 9vHPV vaccine dose administered ≥1 year after the first.METHODSThis open-label safety and immunogenicity ...
Nicola P, Klein, Amy, Wiesner, Oliver, Bautista, Thomas, Group, Kevin, Kanu, Zhongyi Lucy, Li, Jennifer, McCauley, Kunal, Saxena, Joseph, Tota, Alain, Luxembourg, Rachael, Bonawitz   +10 more
openaire   +2 more sources

Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis

Med, 2023
Katrin Pape, Frauke Zipp, Stefan Bittner
exaly  

Extended dosing of monoclonal antibodies in multiple sclerosis

Multiple Sclerosis Journal, 2022
Gavin Giovannoni, Finn Sellebjerg, Joep Killestein   +2 more
exaly  

Progressive multifocal leukoencephalopathy with natalizumab extended or standard interval dosing in the United States and the rest of the world

Expert Opinion on Drug Safety, 2023
Karen Smirnakis, Robert Kuhelj, Liesel Dsilva   +2 more
exaly  

Effectiveness of Natalizumab in Extended Dosing Interval (P3.078)

Neurology, 2016
Jose Vicente Hervas, Joan Punet-Ortiz, Aina Teniente-Serra, M Jos Mansilla, Bibiana Quirant-Sanchez, Juan Navarro, Silvia Presas, Eva Martinez-Caceres, Cristina Ramo   +8 more
openaire   +1 more source

Wearing-off symptoms during standard and extended natalizumab dosing intervals: Experiences from the COVID-19 pandemic

Journal of the Neurological Sciences, 2021
Nello Blaser, Kjell-Morten Myhr, Gerd Haga Bringeland   +2 more
exaly  

Extended Interval Gentamicin Dosing in Burn Patients

Journal of Burn Care & Rehabilitation, 2001
K. L. Brown, P. R. Mayo, H. A. Shankowsky, E. E. Tredget   +3 more
openaire   +1 more source

Efficacy of Omalizumab Using Extended Dose Intervals

Journal of Allergy and Clinical Immunology, 2007
R.M. Katz, A.W. Rafi, L. Do, M. Lin, R. Mangat, N. Azad, S. Sender   +6 more
openaire   +1 more source

Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer

Clinical Lung Cancer, 2021
Meghan Shea, Deepa Rangachari
exaly